CasePit
AAPLTSLAMSFTNVDAAMZNGOOGLMETAAMDNFLXPLTRCOINJPM
AAPLTSLAMSFTNVDAAMZNGOOGLMETAAMDNFLXPLTRCOINJPM
Post DDLog in
  • Feed
  • Discover
  • Watchlist
  • Messages
  • Profile

Verify your position

Show a βœ“ badge on your posts. Proof beats opinion.

Add a position

Trending now

Promoted

Something missing?

s/wishlist is where features get requested, argued over, and built.

Open s/wishlist β†’

Not financial advice. Prices are delayed. Verified positions reflect a point-in-time check, not current holdings.

CasePit is a community discussion platform. Nothing here is financial advice, an offer, or a recommendation to buy or sell any security. Verified positions show what a member held at the time of verification, not what they hold now. Prices are delayed and provided for information only. Do your own research.

πŸ“± CasePit for iOS is in the works.

  • About
  • Congress
  • Insiders
  • Terms of Service
  • Privacy Policy
  • Risk Notice
  • Imprint
  • Moderation notices
  • Feed
  • Discover
  • +
  • Watchlist
  • Profile

MDT

Medtronic plc.

Open
High
Low
Prev close
Volume

About Medtronic plc.

Medtronic plc. (MDT) is a Healthcare company in the Electromedical & Electrotherapeutic Apparatus industry with a market capitalisation of $122.6B. The stock trades at 23.50x trailing earnings and yields 3%.

Sector
Healthcare
Industry
Electromedical & Electrotherapeutic Apparatus
Market cap
$122.6B
P/E ratio
23.50
EPS (TTM)
$3.73
Revenue (TTM)
$36.4B
Free cash flow
$5.4B
Profit margin
0.0%
Dividend yield
3%
Shares outstanding
1.3B

Financial health: Fair5/10

3 strengths, 3 concerns. Weakest points: return on equity, net margin, payout ratio.

  • Current ratio: 2.13 (Strong, benchmark > 1.5) β€” Short-term assets cover 2.13x short-term liabilities, against Graham's 1.5x floor. It has deteriorated over the last 4 years.
  • Return on equity: 0.0% (Concern, benchmark > 15%) β€” Earns 0.0% on shareholder equity, well short of the > 15% mark.
  • Gross margin: 65.0% (Strong, benchmark > 40%) β€” Keeps 65.0% of revenue after the direct cost of sales, comfortably past the > 40% mark.
  • Net margin: 0.0% (Concern, benchmark > 10%) β€” Turns 0.0% of revenue into profit, well short of the > 10% mark.
  • Free cash flow: $5.4B (Strong, benchmark positive) β€” Generated $5.4B of free cash flow after capital spending. It has improved over the last 4 years.
  • Revenue growth: 8.4% (Watch, benchmark > 10%) β€” Revenue changed 8.4% year on year, short of the > 10% mark.
  • Earnings growth: 3.0% (Watch, benchmark > 10%) β€” Earnings changed 3.0% year on year, short of the > 10% mark.
  • Payout ratio: 75796709.0% (Concern, benchmark < 60%) β€” Pays out 75796709.0% of earnings as dividends β€” above the level usually considered sustainable.

AI take

AI-generated Β· not financial advice

MDT news

Promoted

Something missing?

s/wishlist is where features get requested, argued over, and built.

Open s/wishlist β†’

Discussion in s/MDT